Biofluids manipulation methods for liquid biopsy in minimally-invasive assays
- PMID: 35774416
- PMCID: PMC9237943
- DOI: 10.1016/j.mex.2022.101759
Biofluids manipulation methods for liquid biopsy in minimally-invasive assays
Abstract
The Liquid Biopsy (LB) is an opportunity for non-invasive diagnosis and prognosis of various diseases. To date, it isn't possible to consider that tissue biopsy can represent a pathology entirety. Then, body fluids are rich in a large number and variety of biomarkers and they can provide information about several diseases.•Recently, other biological fluids, easy to be collected are rising for their significant content of biomarkers and for the possibility to collect and manipulate them without the intervention of medical staff.•The management of biological fluids requires suitable storage methods. Temperature, storage time and physical stresses due to sample handling can lead to chemical and physical changes that may induce sample degradation and incorrect analysis.•The reliability of a diagnostic or screening test depends on its sensitivity and specificity. As the liquid biopsy is a 'snapshot' of a pathophysiological condition, it is crucial that its components do not degrade due to the improper handling of the body fluid.In this review, some handling methods of Saliva, Urine, Stool, Seminal Fluid, Tears and Sweat samples will be described, as well as protocols to facilitate the analysis of metabolites, nucleic acids, proteins and Extracellular Vesicles (EVs) from those unusual body fluids.
Keywords: Biomarkers; Body fluid; Diagnosis; Sample handling; Screening.
© 2022 The Authors. Published by Elsevier B.V.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures




Similar articles
-
Urine as a Source of Liquid Biopsy for Cancer.Cancers (Basel). 2021 May 28;13(11):2652. doi: 10.3390/cancers13112652. Cancers (Basel). 2021. PMID: 34071230 Free PMC article. Review.
-
Identification of potential saliva and tear biomarkers in primary Sjögren's syndrome, utilising the extraction of extracellular vesicles and proteomics analysis.Arthritis Res Ther. 2017 Jan 25;19(1):14. doi: 10.1186/s13075-017-1228-x. Arthritis Res Ther. 2017. PMID: 28122643 Free PMC article.
-
Urinary extracellular vesicles: a rising star in bladder cancer management.Transl Androl Urol. 2021 Apr;10(4):1878-1889. doi: 10.21037/tau-20-1039. Transl Androl Urol. 2021. PMID: 33968676 Free PMC article. Review.
-
MALDI-TOF/MS Analysis of Non-Invasive Human Urine and Saliva Samples for the Identification of New Cancer Biomarkers.Molecules. 2022 Mar 16;27(6):1925. doi: 10.3390/molecules27061925. Molecules. 2022. PMID: 35335287 Free PMC article. Review.
-
Identification and detection of protein markers to differentiate between forensically relevant body fluids.Forensic Sci Int. 2018 Sep;290:196-206. doi: 10.1016/j.forsciint.2018.07.013. Epub 2018 Jul 24. Forensic Sci Int. 2018. PMID: 30071450
Cited by
-
Liquid biopsy in gastric cancer: A snapshot of the current state of the art.J Liq Biopsy. 2025 Jan 20;7:100288. doi: 10.1016/j.jlb.2025.100288. eCollection 2025 Mar. J Liq Biopsy. 2025. PMID: 40027230 Free PMC article. Review.
-
Challenges and Opportunities for Extracellular Vesicles in Clinical Oncology Therapy.Bioengineering (Basel). 2023 Mar 3;10(3):325. doi: 10.3390/bioengineering10030325. Bioengineering (Basel). 2023. PMID: 36978715 Free PMC article. Review.
-
Epitranscriptomic alterations induced by environmental toxins: implications for RNA modifications and disease.Genes Environ. 2025 Aug 4;47(1):14. doi: 10.1186/s41021-025-00337-9. Genes Environ. 2025. PMID: 40760453 Free PMC article. Review.
-
Advances in Non-Electrochemical Sensing of Human Sweat Biomarkers: From Sweat Sampling to Signal Reading.Biosensors (Basel). 2023 Dec 28;14(1):17. doi: 10.3390/bios14010017. Biosensors (Basel). 2023. PMID: 38248394 Free PMC article. Review.
-
Miniaturized Real-Time PCR systems for SARS-CoV-2 detection at the Point-of-Care.Clin Chim Acta. 2022 Nov 1;536:104-111. doi: 10.1016/j.cca.2022.09.014. Epub 2022 Sep 17. Clin Chim Acta. 2022. PMID: 36126763 Free PMC article. Review.
References
-
- Dong X., Zheng T., Zhang M., Dai C., Wang L., Wang L., Zhang R., Long Y., Wen D., Xie F., Zhang Y., Huang Y., Dong J., Liu H., Du P., King B.L., Tan W., Jia S., Lu C.X., Kohli M., Wang H., Yu J. Circulating cell-free DNA-based detection of tumor suppressor gene copy number loss and its clinical implication in metastatic prostate cancer. Front. Oncol. 2021;11:1–7. doi: 10.3389/fonc.2021.720727. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials